Race Oncology accelerates gamechanging cancer drug
In this HotCopper Capital Compass interview, Race Oncology (ASX:RAC) chairman Dr Pete Smith discusses the company’s “safe and successful”
New Analyst Report Lifts Almonty Target Price to CDN$5.50
Lyndsay Malchuk sits with GBC Analyst, Matthias Greiffenberger to dive into the price target raise to…
Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals
With biotech stocks broadly having a strong run in 2025, and with more of the year…
Building the most significant non-Chinese tungsten source on the map
Without Tungsten missiles don't fly straight, drills don't cut, and that phone you hold so diligently…
Tungsten: Building the next-generation of defense systems
Now, most of the world has heard about this company, Almonty Industries.
The worldwide impact on business from China’s commodity sanctions
The Market Online’s Lyndsay Malchuk sits down with GBC Investment Research analyst Matthias Greiffenberger to talk China’s latest commodity sanctions – and how
Chinese sanctions raise the stakes for tungsten production at Sangdong
The Market Online’s Lyndsay Malchuk sits down with Lewis Black, Director, President, and Chief Executive Officer at
Shaping the future of tungsten supply: Opportunities and global impact
Almonty Industries (ASX:AII) has entered an exclusive offtake agreement with SeAH M&S, the largest processor of molybdenum products in
Sphene Capital analyst discusses the tungsten market and Almonty Industries
As deglobalisation shapes supply chains, tungsten is emerging as a critical resource for sectors like defence and artificial intelligence.
Is a lithium revival on the cards in 2025? Chariot Corporation say yes!
Chariot Corporation Ltd is confident that despite 2 years of downturn in lithium prices, the future…